BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 19019178)

  • 21. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
    Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
    Reyaz N; Tayyab M; Khan SA; Siddique T
    J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P53 immunoexpression as a prognostic marker for human astrocytomas: a meta-analysis and review of the literature.
    Levidou G; El-Habr E; Saetta AA; Bamias C; Katsouyanni K; Patsouris E; Korkolopoulou P
    J Neurooncol; 2010 Dec; 100(3):363-71. PubMed ID: 20461443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. J1-31 protein expression in astrocytes and astrocytomas.
    Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA
    Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gliosis versus glioma?: don't grade until you know.
    Rivera-Zengotita M; Yachnis AT
    Adv Anat Pathol; 2012 Jul; 19(4):239-49. PubMed ID: 22692287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathologic analysis of primary brain tumors.
    McComb RD; Burger PC
    Neurol Clin; 1985 Nov; 3(4):711-28. PubMed ID: 3001488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ultrastructure of glial tumors of astrocytic lineage: a review.
    Liberski PP
    Folia Neuropathol; 1998; 36(3):161-77. PubMed ID: 9833393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteins of the intermediate filament cytoskeleton as markers for astrocytes and human astrocytomas.
    Yang HY; Lieska N; Shao D; Kriho V; Pappas GD
    Mol Chem Neuropathol; 1994; 21(2-3):155-76. PubMed ID: 7522006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. So-called massive retinal gliosis: A critical review and reappraisal.
    Jakobiec FA; Thanos A; Stagner AM; Grossniklaus HE; Proia AD
    Surv Ophthalmol; 2016; 61(3):339-56. PubMed ID: 26703887
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.